Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...
Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...
SoundHound AI (SOUN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ...
There's robust potential in US tech, pharma and Qantas, while red flags exist in a number of ASX companies that make them ...